Immucor DX
Novel technologies and unique services are not readily or easily available to everyone. Immucor’s Reference Laboratory, Immucor DX, leverages our expertise and new technology to accelerate availability and provide access and support to our laboratory customers, clinicians and the patients we all serve.
Recent Updates
Expand
Post-Transplant Monitoring
Post Transplant Monitoring
We offer a non-invasive alternative to surveillance biopsies, giving patients few costly procedures, with less risk and earlier detection.
Expand
Transfusion Molecular Testing
Transfusion Molecular Testing
Bring innovative tools to your lab to provide the closest match possible between a patient and a donor.
- Testimonial
- Transplant
- Customer
I really appreciate Immucor's continuous interest in listening to the customer. That is what makes Immucor a great partner to our labs. I know that our needs and ideas will be heard and taken into consideration to improve the products. That makes a world of difference to us in the labs and is truly appreciated.
Valia Bravo-Egana, PhD, F(ACHI), MBA, Director, Technical Supervisor and Clinical Consultant, Histocompatibility/Immunology Laboratory, Medical College of Georgia
- Testimonial
- Transplant
- Customer
Immucor products enable us to accurately assign HLA antibody specificities for better transplant outcomes!
Sam Ho, PhD, D(ABHI), FAACC, HLA Lab Director, Gift of Hope Organ & Tissue Donor Network
- Testimonial
- Transplant
- Customer
The fact that Immucor representatives are former transplant technologists adds one more layer of support for us. I appreciate Immucor's commitment to comprehensive customer support, from assay and software development to technical and educational support. It's a team approach between vendor and customer that is more than a business relationship. It's a joint mission to benefit patients.
Ellen Klohe, PhD, D(ABHI), HLA Laboratory Director, Vitalant Spokane Laboratory
Labs We Serve
Select your lab type:
Upcoming Events,
Webinars & Workshops
Upcoming Event
ISHI webinar session on Impact of HLA-DP in Solid Organ and Bone Marrow Transplantation
When
March 31st 2023
Where
Virtual
Keep Up With Us
News & Blogs
Werfen Completes Acquisition of Immucor, Inc.
WERFEN COMPLETES ACQUISITION OF IMMUCOR, INC., EXPANDING LEADERSHIP IN SPECIALIZED DIAGNOSTICS Werfen announced in November 2022 that it reached an agreement to acquire Immucor, Inc. for approximately US$2 billion. The transaction has received all necessary regulatory approvals. The Transfusion and...
News & Blogs
EFI 2023 - Bienvenue à Nantes, France!
Immucor is excited to see you at EFI 2023 - Bienvenue à Nantes, France! As...
News & Blogs
PRESS RELEASE: Immucor and Pirche Announce Multi-Year Partnership
NORCROSS, Ga. and BERLIN, DE Oct. 04, 2022 (GLOBE NEWSWIRE) -- Immucor, Inc., a global...
News & Blogs
PRESS RELEASE: Immucor Announces New Innovations in Transplant Diagnostics
NORCROSS, Ga., March 04, 2022 (GLOBE NEWSWIRE) -- Immucor, Inc., a global leader in transfusion...
News & Blogs
MIA FORATM NGS EXPRESS HLA Typing Software: You Spoke, We Listened!
Introducing MIA FORA NGS EXPRESS HLA Typing Software, Immucor’s next step in providing value-added user...
